TG Therapeutics, Inc.
TGTX Real Time Price USDRecent trades of TGTX by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Chris Jacobs House / R | Sale $1,001 - $15,000 | Sep. 08, 2020 |
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by TGTX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Anti-cd20 antibody compositions Apr. 23, 2024
-
Patent Title: Anti-cd20 antibody compositions Jan. 30, 2024
-
Patent Title: Anti-cd20 antibody compositions Nov. 14, 2023
-
Patent Title: Anti-cd20 antibody compositions Nov. 07, 2023
-
Patent Title: Combination of anti-cd20 antibody, p13 kinase-delta selective inhibitor, and btk inhibitor to treat b-cell proliferative disorders Apr. 06, 2021
-
Patent Title: Combination of anti-cd20 antibody and pi3 kinase selective inhibitor Aug. 04, 2020
-
Patent Title: Combination of anti-cd20 antibody and pi3 kinase selective inhibitor Jul. 04, 2017
Federal grants, loans, and purchases
- $0 2024-04-17 00:00:00 Agency: Department of Veterans Affairs
- $0 2023-05-05 00:00:00 Agency: Department of Veterans Affairs
- $0 2023-01-23 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $0 2021-07-29 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $0 2021-03-12 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Estimated quarterly amount awarded from public contracts
Number of mentions of TGTX in WallStreetBets Daily Discussion
Recent insights relating to TGTX
Recent picks made for TGTX stock on CNBC
ETFs with the largest estimated holdings in TGTX
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view TGTX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.